Caroline Galeotti

Summary

Publications

  1. doi request reprint [Value of whole-body MRI in vertebral fractures]
    C Galeotti
    Service de Pediatrie Generale, Rhumatologie Pédiatrique, Centre national de référence des maladies auto inflammatoires, CEREMAI, CHU Bicetre, 78, rue du General Leclerc, 94270 Le Kremlin Bicetre, France Electronic address
    Arch Pediatr 22:279-82. 2015
  2. doi request reprint [Management of monoarthritis in children]
    C Galeotti
    Service de Pediatrie Generale, Rhumatologie Pédiatrique, Centre national de référence des maladies auto inflammatoires, CEREMAI, Universite de Paris Sud, CHU Bicetre, AP HP, 78, rue du General Leclerc, 94270 Le Kremlin Bicetre, France
    Arch Pediatr 19:1374-8. 2012
  3. doi request reprint Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody
    Caroline Galeotti
    Department of Pediatrics, Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU de Bicetre, Le Kremlin Bicetre, France
    Mol Cancer Ther 11:1623-6. 2012
  4. doi request reprint Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
    Linda Rossi-Semerano
    Department of Paediatric Rheumatology, Hopital de Bicetre, APHP, National Reference Centre for Auto Inflammatory Diseases, Le Kremlin Bicetre, University of Paris Sud, CHU de Bicêtre 78 Rue du Général Leclerc, 94270, Le Kremlin, Bicetre, France
    Orphanet J Rare Dis 10:19. 2015
  5. doi request reprint IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report
    Caroline Galeotti
    Department of Pediatrics, Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CHU de Bicetre, Le Kremlin Bicetre, France
    J Pediatr Hematol Oncol 30:920-4. 2008
  6. doi request reprint Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis
    Alain Lefèvre-Utile
    Department of Paediatrics, Paediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU de Bicetre, AP HP, University of Paris Sud, 94275 Le Kremlin Bicetre, France
    Joint Bone Spine 81:257-9. 2014
  7. ncbi request reprint Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
    Caroline Galeotti
    Department of Pediatrics and Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU Bicetre, Assistance Publique Hopitaux de Paris, University of Paris Sud, Le Kremlin Bicetre, France
    Rheumatology (Oxford) 51:1855-9. 2012

Collaborators

Detail Information

Publications7

  1. doi request reprint [Value of whole-body MRI in vertebral fractures]
    C Galeotti
    Service de Pediatrie Generale, Rhumatologie Pédiatrique, Centre national de référence des maladies auto inflammatoires, CEREMAI, CHU Bicetre, 78, rue du General Leclerc, 94270 Le Kremlin Bicetre, France Electronic address
    Arch Pediatr 22:279-82. 2015
    ..In this perspective, wbMRI is a major noninvasive tool to assess the diagnosis of CRMO, and allows avoiding a bone biopsy in most cases. ..
  2. doi request reprint [Management of monoarthritis in children]
    C Galeotti
    Service de Pediatrie Generale, Rhumatologie Pédiatrique, Centre national de référence des maladies auto inflammatoires, CEREMAI, Universite de Paris Sud, CHU Bicetre, AP HP, 78, rue du General Leclerc, 94270 Le Kremlin Bicetre, France
    Arch Pediatr 19:1374-8. 2012
    ..This article presents the clinical approach to the diagnosis of monoarthritis as well as the different causes of monoarthritis in children...
  3. doi request reprint Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody
    Caroline Galeotti
    Department of Pediatrics, Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU de Bicetre, Le Kremlin Bicetre, France
    Mol Cancer Ther 11:1623-6. 2012
    ..This patient benefited from sustained remission for a period of 3 years. Tocilizumab was effective and safe in these two children with MCD...
  4. doi request reprint Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
    Linda Rossi-Semerano
    Department of Paediatric Rheumatology, Hopital de Bicetre, APHP, National Reference Centre for Auto Inflammatory Diseases, Le Kremlin Bicetre, University of Paris Sud, CHU de Bicêtre 78 Rue du Général Leclerc, 94270, Le Kremlin, Bicetre, France
    Orphanet J Rare Dis 10:19. 2015
    ..We aimed to estimate the off-label use of anti-IL-1 treatments in France, assess their efficacy in rare diseases, and increase the reporting of their possible side effects...
  5. doi request reprint IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report
    Caroline Galeotti
    Department of Pediatrics, Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CHU de Bicetre, Le Kremlin Bicetre, France
    J Pediatr Hematol Oncol 30:920-4. 2008
    ..This is the first report of anakinra treatment for MCD. We conclude that anti-IL-1 blocking agents could be an interesting treatment alternative for MCD, a chronic debilitating disease, which still carries a poor prognosis...
  6. doi request reprint Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis
    Alain Lefèvre-Utile
    Department of Paediatrics, Paediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU de Bicetre, AP HP, University of Paris Sud, 94275 Le Kremlin Bicetre, France
    Joint Bone Spine 81:257-9. 2014
    ..All but one patient finally needed biologic treatments. Coronary abnormalities may be observed during various febrile conditions and do not exclude the diagnosis of Still's disease. ..
  7. ncbi request reprint Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
    Caroline Galeotti
    Department of Pediatrics and Pediatric Rheumatology, National Referral Centre of Auto inflammatory Diseases, CEREMAI, CHU Bicetre, Assistance Publique Hopitaux de Paris, University of Paris Sud, Le Kremlin Bicetre, France
    Rheumatology (Oxford) 51:1855-9. 2012
    ..To describe the efficacy and safety of IL-1-targeting drugs, anakinra and canakinumab, in patients with mevalonate kinase deficiency (MKD)...